Good morning, everyone, and how are you today? We are doing just fine, thank you, as we make our way through a three-day jaunt to the corporate nerve center for different gatherings. We are fortified, ...

Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are currently enveloping the placid Pharmalot campus, where the official mascots are snoozing cozily in their ...

The White House and the Department of Health and Human Services have announced the names of the first set of Part B prescription drugs that will be subject to Medicare inflation rebates because they ...

Another major pharmacy benefit manager is adding Humira biosimilars to its formulary beginning next year. Express Scripts, which is part of Cigna's Evernorth subsidiary, said Monday that it will add ...

LAS VEGAS—Optum Rx is planning to add up to three biosimilar drugs to its formulary to compete directly with AbbVie's Humira, which accounts for massive pharmacy spend each year. Optum Rx, the ...

The Biosimilars Council, a division of the Association for Accessible Medicines, released a blog as well as an analysis conducted by Avalere on biosimilar coverage, tiering and management in Medicare ...

Pfizer has received the Food and Drug Administration’s clearance for Abrilada (adalimumab-afzb). The product is a biosimilar to AbbVIe’s Humira (adalimumab). It is indicated for the treatment of ...

Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar versions as part of its Biosimilars Initiative. Alberta, Canada has expanded ...

Humira (adalimumab) is a prescription drug that’s used to treat certain types of arthritis and other inflammation-related diseases. It comes as a liquid solution for injection under your skin. Humira ...

North Chicago-based drugmaker AbbVie must pay back Medicare for raising the price of its blockbuster drug Humira too quickly, the federal government said Wednesday. The penalty follows years of ...